Meningococcal polysaccharide vaccine failure in a patient with C7 deficiency and a decreased anti-capsular antibody response

Human Vaccines and Immunotherapeutics

Volumn 8, Issue 5, 2012, Pages 582-586

  Keiser, Paul B ^a   Broderick, Michael ^b  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

^b NAVAL MEDICAL CENTER SAN DIEGO   (United States)

Author keywords

C7; Complement deficiency; Meningococcus; Military; Neisseria; Vaccine

Indexed keywords

AMPICILLIN; COMPLEMENT COMPONENT C7; CREATININE; MENINGOCOCCUS VACCINE; MEROPENEM; POLYSACCHARIDE VACCINE;

ADULT; ANTIBODY RESPONSE; ARTICLE; BACTERIUM IDENTIFICATION; BLOOD CULTURE; BRAIN HEMORRHAGE; CASE REPORT; CEREBROSPINAL FLUID CULTURE; CLINICAL FEATURE; COMPLEMENT HEMOLYSIS TEST; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG ERUPTION; DRUG RESPONSE; DRUG SUBSTITUTION; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; HUMAN; LEUKOCYTE COUNT; MALE; MENINGOCOCCOSIS; NEISSERIA MENINGITIDIS; NONHUMAN; PARTIAL THROMBOPLASTIN TIME; PH; PROTHROMBIN TIME; THROMBOCYTE COUNT; VACCINE FAILURE;

ANTIBODIES, BACTERIAL; COMPLEMENT C7; FATAL OUTCOME; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; MALE; MENINGOCOCCAL INFECTIONS; MENINGOCOCCAL VACCINES; NEISSERIA MENINGITIDIS, SEROGROUP Y; SEPSIS; YOUNG ADULT;

EID: 84863666383     PISSN: None     EISSN: 2164554X     Source Type: Journal    
DOI: 10.4161/hv.19517     Document Type: Article

References (44)

1. Ross SC, Densen P. Complement deficiency states and infection: epidemiology, pathogenesis and consequences of neisserial and other infections in an immune deficiency. Medicine (Baltimore) 1984; 63:243-73; PMID: 6433145.
2. D'Amelio R, Agostoni A, Biselli R, Brai M, Caruso G, Cicardi M, et al. Complement deficiency and antibody profile in survivors of meningococcal meningitis due to common serogroups in Italy. Scand J Immunol 1992; 35:589-95; PMID: 1579859; DOI: 10.1111/j.1365-3083.1992.tb03258.x.
3. Kallel-Sellami M, Abdelmalek R, Zerzeri Y, Laadhar L, Blouin J, Zitouni M, et al. Déficits héréditaires en protéines du complément au cours des méningites purulentes: étude de 61 patients adultes tunisiens et revue de la littérature. Arch Inst Pasteur Tunis 2006; 83:25-34; PMID: 19388594.
4. Hibberd ML, Sumiya M, Summerfield JA, Booy R, Levin M. Association of variants of the gene for mannose-binding lectin with susceptibility to meningococcal disease. Lancet 1999; 353:1049-53; PMID: 10199352; DOI: 10.1016/S0140-6736(98)08350-0.
5. Bax WA, Cluysenaer OJ, Bartelink AK, Aerts PC, Ezekowitz RA, van Dijk H. Association of familial deficiency of mannose-binding lectin and meningococcal disease. Lancet 1999; 354:1094-5; PMID: 10509505; DOI: 10.1016/S0140-6736(99) 02563-5.
6. Kuijper EJ, Fijen CA, Dankert J, Thiel S. Mannose-binding lectin and meningococcal disease. Lancet 1999; 354:338; PMID: 10440336; DOI: 10.1016/S0140-6736(05)75244-2.
7. Eisen DP, Minchinton RM. Impact of mannose-binding lectin on susceptibility to infectious diseases. Clin Infect Dis 2003; 37:1496-505; PMID: 14614673; DOI: 10.1086/379324.
8. Salit IE. Meningococcemia caused by serogroup W135. Association with hypogammaglobulinemia. Arch Intern Med 1981; 141:664-5; PMID: 6784688; DOI: 10.1001/archinte.1981.00340050110026.
9. Densen P. Complement deficiencies and infection. In: Volanakis JE, Frank MM, eds. The Human Complement System in Health and Disease. M Dekker, 1998: 409-421.
10. Bishof NA, Welch TR, Beischel LS. C4B deficiency: a risk factor for bacteremia with encapsulated organisms. J Infect Dis 1990; 162:248-50; PMID: 2355198; DOI: 10.1093/infdis/162.1.248.
11. Densen P, Weiler JM, Griffiss JM, Hoffmann LG. Familial properdin deficiency and fatal meningococcemia. Correction of the bactericidal defect by vaccination. N Engl J Med 1987; 316:922-6; PMID: 3102964; DOI: 10.1056/NEJM198704093161506.
12. Sprong T, Roos D, Weemaes C, Neeleman C, Geesing CL, Mollnes TE, et al. Deficient alternative complement pathway activation due to factor D deficiency by 2 novel mutations in the complement factor D gene in a family with meningococcal infections. Blood 2006; 107:4865-70; PMID: 16527897; DOI: 10.1182/blood-2005-07-2820.
13. Cunliffe NA, Snowden N, Dunbar EM, Haeney MR. Recurrent meningococcal septicaemia and properdin deficiency. J Infect 1995; 31:67-8; PMID: 8522838; DOI: 10.1016/S0163-4453(95)91550-8.
14. S Reis E, Falcão DA, Isaac L. Clinical aspects and molecular basis of primary deficiencies of complement component C3 and its regulatory proteins factor I and factor H. Scand J Immunol 2006; 63:155-68; PMID: 16499568; DOI: 10.1111/j.1365-3083.2006.01729.x.
15. Nielsen HE, Christensen KC, Koch C, Thomsen BS, Heegaard NH, Tranum-Jensen J. Hereditary, complete deficiency of complement factor H associated with recurrent meningococcal disease. Scand J Immunol 1989; 30:711-8; PMID: 2532396; DOI: 10.1111/j.1365-3083.1989.tb02480.x.
16. Thompson RA, Lachmann PJ. A second case of human C3b inhibitor (KAF) deficiency. Clin Exp Immunol 1977; 27:23-9; PMID: 849647.
17. Teisner B, Elling P, Svehag SE, Poulsen L, Lamm LU, Sjöholm A. C3 nephritic factor in a patient with recurrent Neisseria meningitidis infections. Acta Pathol Microbiol Immunol Scand C 1984; 92:341-9; PMID: 6570081.
18. Ducret F, Decoux M, Pointet P, Lambert C, Grosperrin E, Sédaillan A. Déficit héréditaire en C5 et méningite récidivante àNeisseria meningitidis. Rev Med Interne 1988; 9:534-7; PMID: 3067301; DOI: 10.1016/S0248-8663(88)80021-3.
19. Lim D, Gewurz A, Lint TF, Ghaze M, Sepheri B, Gewurz H. Absence of the sixth component of complement in a patient with repeated episodes of meningococcal meningitis. J Pediatr 1976; 89:42-7; PMID: 819642; DOI: 10.1016/S0022-3476(76)80924-9.
20. Lee TJ, Utsinger PD, Snyderman R, Yount WJ, Sparling PF. Familial deficiency of the seventh component of complement associated with recurrent bacteremic infections due to Neisseria. J Infect Dis 1978; 138:359-68; PMID: 100562; DOI: 10.1093/infdis/138.3.359.
21. Petersen BH, Lee TJ, Snyderman R, Brooks GF. Neisseria meningitidis and Neisseria gonorrhoeae bacteremia associated with C6, C7, or C8 deficiency. Ann Intern Med 1979; 90:917-20; PMID: 109025.
22. Zoppi M, Weiss M, Nydegger UE, Hess T, Späth PJ. Recurrent meningitis in a patient with congenital deficiency of the C9 component of complement. First case of C9 deficiency in Europe. Arch Intern Med 1990; 150:2395-9; PMID: 2241452; DOI: 10.1001/archinte.1990.00390220127027.
23. Andreoni J, Käyhty H, Densen P. Vaccination and the role of capsular polysaccharide antibody in prevention of recurrent meningococcal disease in late complement component-deficient individuals. J Infect Dis 1993; 168:227-31; PMID: 8515116; DOI: 10.1093/infdis/168.1.227.
24. Wedege E, Høiby EA, Rosenqvist E, Bjune G. Immune responses against major outer membrane antigens of Neisseria meningitidis in vaccinees and controls who contracted meningococcal disease during the Norwegian serogroup B protection trial. Infect Immun 1998; 66:3223-31; PMID: 9632589.
25. Schmiel DH, Moran EE, Keiser PB, Brandt BL, Zollinger WD. Importance of antibodies to lipopolysaccharide in natural and vaccine-induced serum bactericidal activity against Neisseria meningitidis group B. Infect Immun 2011; 79:4146-56; PMID: 21768280; DOI: 10.1128/IAI.05125-11.
26. Fijen CA, Kuijper EJ, Hannema AJ, Sjöholm AG, van Putten JP. Complement deficiencies in patients over ten years old with meningococcal disease due to uncommon serogroups. Lancet 1989; 2:585-8; PMID: 2570284; DOI: 10.1016/S0140-6736(89)90712-5.
27. Fijen CA, Kuijper EJ, Tjia HG, Daha MR, Dankert J. Complement deficiency predisposes for meningitis due to nongroupable meningococci and Neisseria-related bacteria. Clin Infect Dis 1994; 18:780-4; PMID: 8075270; DOI: 10.1093/clinids/18.5.780.
28. Goldschneider I, Gotschlich EC, Artenstein MS. Human immunity to the meningococcus. I. The role of humoral antibodies. J Exp Med 1969; 129:1307-26; PMID: 4977280; DOI: 10.1084/jem.129.6.1307.
29. Jodar L, Cartwright K, Feavers IM. Standardisation and validation of serological assays for the evaluation of immune responses to Neisseria meningitidis serogroup A and C vaccines. Biologicals 2000; 28:193-7; PMID: 10964447; DOI: 10.1006/biol.2000.0253.
30. Schlesinger M, Greenberg R, Levy J, Kayhty H, Levy R. Killing of meningococci by neutrophils: effect of vaccination on patients with complement deficiency. J Infect Dis 1994; 170:449-53; PMID: 8035035; DOI: 10.1093/infdis/170.2.449.
31. Biselli R, Casapollo I, D'Amelio R, Salvato S, Matricardi PM, Brai M. Antibody response to meningococcal polysaccharides A and C in patients with complement defects. Scand J Immunol 1993; 37:644-50; PMID: 8316762; DOI: 10.1111/j.1365-3083.1993.tb01677.x.
32. Platonov AE, Beloborodov VB, Pavlova LI, Vershinina IV, Käyhty H. Vaccination of patients deficient in a late complement component with tetravalent meningococcal capsular polysaccharide vaccine. Clin Exp Immunol 1995; 100:32-9; PMID: 7697919; DOI: 10.1111/j.1365-2249.1995.tb03600.x.
33. Platonov AE, Vershinina IV, Kuijper EJ, Borrow R, Käyhty H. Long term effects of vaccination of patients deficient in a late complement component with a tetravalent meningococcal polysaccharide vaccine. Vaccine 2003; 21:4437-47; PMID: 14505927; DOI: 10.1016/S0264-410X(03)00440-7.
34. Drogari-Apiranthitou M, Fijen CA, Van De Beek D, Hensen EF, Dankert J, Kuijper EJ. Development of antibodies against tetravalent meningococcal polysaccharides in revaccinated complement-deficient patients. Clin Exp Immunol 2000; 119:311-6; PMID: 10632668; DOI: 10.1046/j.1365-2249.2000.01130.x.
35. Herva E, Leinonen M, Käyhty H, Mäkelä PH, Vetoniemi-Korhonen SL. Recurrent meningococcal meningitis due to partial complement defects and poor anti-meningococcal antibody response. J Infect 1983; 6:55-60; PMID: 6411822; DOI: 10.1016/S0163-4453(83)95636-0.
36. Zangwill KM, Stout RW, Carlone GM, Pais L, Harekeh H, Mitchell S, et al. Duration of antibody response after meningococcal polysaccharide vaccination in US Air Force personnel. J Infect Dis 1994; 169:847-52; PMID: 8133100; DOI: 10.1093/infdis/169.4.847.
37. Platonov AE, Beloborodov VB, Vershinina IV. Meningococcal disease in patients with late complement component deficiency: studies in the U.S.S.R. Medicine (Baltimore) 1993; 72:374-92; PMID: 8231787; DOI: 10.1097/00005792- 199311000-00002.
38. Fijen CA, Kuijper EJ, Drogari-Apiranthitou M, Van Leeuwen Y, Daha MR, Dankert J. Protection against meningococcal serogroup ACYW disease in complement-deficient individuals vaccinated with the tetravalent meningococcal capsular polysaccharide vaccine. Clin Exp Immunol 1998; 114:362-9; PMID: 9844044; DOI: 10.1046/j.1365-2249.1998.00738.x.
39. Updated recommendations for use of meningococcal conjugate vaccines --- Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Morb Mortal Wkly Rep 2011; 60:72-6; PMID: 21270745.
40. Bilukha OO, Rosenstein N. Prevention and control of meningococcal disease. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2005; 54:1-21; PMID: 15917737.
41. Meningococcal conjugate vaccines policy update: booster dose recommendations. Pediatrics 2011; 128:1213-8; DOI: 10.1542/peds.2011-2380.
42. Plested JS, Welsch JA, Granoff DM. Ex vivo model of meningococcal bacteremia using human blood for measuring vaccine-induced serum passive protective activity. Clin Vaccine Immunol 2009; 16:785-91; PMID: 19339487; DOI: 10.1128/CVI.00007-09.
43. Rameix-Welti MA, Régnier CH, Bienaimé F, Blouin J, Schifferli J, Fridman WH, et al. Hereditary complement C7 deficiency in nine families: subtotal C7 deficiency revisited. Eur J Immunol 2007; 37:1377-85; PMID: 17407100; DOI: 10.1002/eji.200636812.
44. Figueroa JE, Densen P. Infectious diseases associated with complement deficiencies. Clin Microbiol Rev 1991; 4:359-95. (Pubitemid 21920404)